Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02561234 |
Title | A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Aeglea Biotherapeutics |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Pinnacle Research | Phoenix | Arizona | 85258 | United States | Details | |
UCLA | Los Angeles | California | 90024 | United States | Details | |
University of Colorado | Aurora | Colorado | 80045 | United States | Details | |
Research Center: Mid Florida Hematology/Oncology Centers | Orange City | Florida | 32763 | United States | Details | |
Dana Farber | Boston | Massachusetts | 02114 | United States | Details | |
Massachusetts General | Boston | Massachusetts | 02114 | United States | Details | |
Washington University | Saint Louis | Missouri | 93110 | United States | Details | |
Columbia University | New York | New York | 10032 | United States | Details | |
Providence Cancer Center | Portland | Oregon | 97213 | United States | Details | |
University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
UTSW | Dallas | Texas | 75390-8852 | United States | Details |